The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease.
Arendt
T
T
Paul Flechsig Institute of Brain Research, Department of Neuroanatomy, University of Leipzig, Germany.
Holzer
M
M
Brückner
M K
MK
Janke
C
C
Gärtner
U
U
D000544:Alzheimer Disease / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000633:toxicity*; D007276:Injections, Intraventricular; D019319:Okadaic Acid / Q000008:administration & dosage / Q000633:toxicity*; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D016875:tau Proteins / Q000378:metabolism
D004791:Enzyme Inhibitors; D016875:tau Proteins; D019319:Okadaic Acid; D010749:Phosphoprotein Phosphatases